JIANG, Yan, Saba HABIBOLLAH, Katarzyna TILGNER, Joseph COLLIN, Tomáš BÁRTA, Jumana Yousuf AL-AAMA, Lenka TESAŘOVÁ, Rafiqul HUSSAIN, Andrew TRAFFORD, Graham KIRKWOOD, Evelyne SERNAGOR, Cyril ELEFTHERIOU, Stefan PRZYBORSKI, Miodrag STOJKOVIC, Majlinda LAKO, Bernard KEAVNEY and Lyle ARMSTRONG. An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS derived cardiac myocytes. Stem cells translational medicine. 2014, vol. 3, No 4, p. 416-423. ISSN 2157-6564. Available from: https://dx.doi.org/10.5966/sctm.2013-0105.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS derived cardiac myocytes
Authors JIANG, Yan (826 United Kingdom of Great Britain and Northern Ireland), Saba HABIBOLLAH (826 United Kingdom of Great Britain and Northern Ireland), Katarzyna TILGNER (826 United Kingdom of Great Britain and Northern Ireland), Joseph COLLIN (826 United Kingdom of Great Britain and Northern Ireland), Tomáš BÁRTA (203 Czech Republic), Jumana Yousuf AL-AAMA (826 United Kingdom of Great Britain and Northern Ireland), Lenka TESAŘOVÁ (203 Czech Republic, guarantor, belonging to the institution), Rafiqul HUSSAIN (826 United Kingdom of Great Britain and Northern Ireland), Andrew TRAFFORD (826 United Kingdom of Great Britain and Northern Ireland), Graham KIRKWOOD (826 United Kingdom of Great Britain and Northern Ireland), Evelyne SERNAGOR (826 United Kingdom of Great Britain and Northern Ireland), Cyril ELEFTHERIOU (826 United Kingdom of Great Britain and Northern Ireland), Stefan PRZYBORSKI (826 United Kingdom of Great Britain and Northern Ireland), Miodrag STOJKOVIC (826 United Kingdom of Great Britain and Northern Ireland), Majlinda LAKO (826 United Kingdom of Great Britain and Northern Ireland), Bernard KEAVNEY (826 United Kingdom of Great Britain and Northern Ireland) and Lyle ARMSTRONG (826 United Kingdom of Great Britain and Northern Ireland).
Edition Stem cells translational medicine, 2014, 2157-6564.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.709
RIV identification code RIV/00216224:14330/14:00074816
Organization unit Faculty of Informatics
Doi http://dx.doi.org/10.5966/sctm.2013-0105
UT WoS 000333938200007
Keywords in English Hypoplastic left heart syndrome; induced pluripotent stem cells; cardiac myocytes; cardiac development; pluripotent stem cell differentiation
Tags cbia-web
Changed by Changed by: Mgr. Lenka Tesařová, Ph.D., učo 78340. Changed: 2/3/2018 10:08.
Abstract
Hypoplastic left heart syndrome (HLHS) is a serious congenital cardiovascular malformation resulting in hypoplasia or atresia of the left ventricle, ascending aorta, aortic and mitral valves. Diminished flow through the left side of the heart is clearly a key contributor to the condition, but any myocardial susceptibility component is as yet undefined. Using recent advances in the field of induced pluripotent stem cells (iPSC), we have been able to generate an iPSC model of HLHS malformation and characterise the properties of cardiac myocytes (CM) differentiated from these and control-iPSC lines. Differentiation of HLHS-iPSC to cardiac lineages revealed changes in the expression of key cardiac markers and a lower ability to give rise to beating clusters when compared to control-iPSC and human embryonic stem cells (hESC). HLHS-iPSC derived CM show a lower level of myofibrillar organisation, persistence of an fetal gene expression pattern, changes in commitment to ventricular versus atriallineages and display different calcium transient patterns and electrophysiological responses to caffeine and beta-adrenergic antagonists when compared to hESC- and control-iPSC derived CM, suggesting that alternative mechanisms to release calcium from intracellular stores such as the inositol triphosphate receptor may exist in HLHS in addition to the ryanodine receptor thought to function in control-iPSC derived CM. Together our findings demonstrate that CM derived from an HLHS patient demonstrate a number of marker expression and functional differences to hESC/control iPSC derived CM, thus providing some evidence that cardiomyocyte-specific factors may influence the risk of HLHS.
Links
CZ.1.07/2.3.00/30.0030, interní kód MUName: Rozvoj lidských zdrojů pro oblast buněčné biologie
Investor: Ministry of Education, Youth and Sports of the CR, 2.3 Human resources in research and development
PrintDisplayed: 25/4/2024 04:30